Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126434631 | 12643463 | 1 | I | 20160809 | 20160811 | 20160811 | EXP | CA-ROCHE-1810897 | ROCHE | REPORTER KNOWN TO HEALTH AUTHORITY, UNKNOWN UNKNOWN. UNKNOWN ;:-. | 54.00 | YR | M | Y | 0.00000 | 20160811 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126434631 | 12643463 | 1 | PS | Enfuvirtide | ENFUVIRTIDE | 1 | Oral | U | 21481 | SOLUTION FOR INJECTION | |||||||||
| 126434631 | 12643463 | 2 | SS | Saquinavir | SAQUINAVIR | 1 | Oral | U | 21785 | ||||||||||
| 126434631 | 12643463 | 3 | SS | INDINAVIR | INDINAVIR | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 4 | SS | STAVUDINE. | STAVUDINE | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 5 | SS | TENOFOVIR | TENOFOVIR | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 6 | SS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 7 | SS | 3TC | LAMIVUDINE | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 8 | SS | 3TC | LAMIVUDINE | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 9 | SS | ATAZANAVIR | ATAZANAVIR | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 10 | SS | DIDANOSINE. | DIDANOSINE | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 11 | SS | DIDANOSINE. | DIDANOSINE | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 12 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 13 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Oral | U | 0 | ||||||||||
| 126434631 | 12643463 | 14 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Oral | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126434631 | 12643463 | 1 | HIV infection |
| 126434631 | 12643463 | 2 | HIV infection |
| 126434631 | 12643463 | 3 | HIV infection |
| 126434631 | 12643463 | 4 | HIV infection |
| 126434631 | 12643463 | 5 | HIV infection |
| 126434631 | 12643463 | 6 | HIV infection |
| 126434631 | 12643463 | 7 | Antiretroviral therapy |
| 126434631 | 12643463 | 9 | Antiretroviral therapy |
| 126434631 | 12643463 | 10 | Antiretroviral therapy |
| 126434631 | 12643463 | 12 | Antiretroviral therapy |
| 126434631 | 12643463 | 13 | Antiretroviral therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126434631 | 12643463 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126434631 | 12643463 | Diplopia | |
| 126434631 | 12643463 | Dysphagia | |
| 126434631 | 12643463 | Eyelid ptosis | |
| 126434631 | 12643463 | Lipodystrophy acquired | |
| 126434631 | 12643463 | Mitochondrial toxicity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |